Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06637631
PHASE2

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Sponsor: Sanofi

View on ClinicalTrials.gov

Summary

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn's Disease (CD). The primary objective of this study is to assess the efficacy of different doses of SAR441566 compared with placebo in participants with moderate to severe CD. This study will have an anticipated duration of up to 59 weeks which will include a screening period of 4 weeks (+7 calendar days if needed), followed by the Main Study (MS) treatment period, lasting 52 weeks, and a 2-week follow-up period after end of treatment for participants not enrolling in the Long Term Safety (LTS) study. The MS period includes a Double-Blind (DB) treatment period with 12 weeks of induction followed by 40 weeks of maintenance. Additionally, an Open Label (OL) period of up to 40 weeks will be offered to eligible participants. The combined duration of the DB maintenance and OL periods cannot exceed 40 weeks, depending on when participants switch.

Official title: A Phase 2, Multinational, Multicenter, Randomized, Doubleblind, Placebocontrolled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Crohn's Disease.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

260

Start Date

2024-12-10

Completion Date

2029-05-23

Last Updated

2026-03-23

Healthy Volunteers

No

Conditions

Interventions

DRUG

SAR441566

Pharmaceutical form: Tablet Route of administration: Oral

DRUG

SAR441566 matching Placebo

Pharmaceutical form: Tablet Route of administration: Oral

Locations (135)

GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400020

Sun City, Arizona, United States

Bristol Hospital- Site Number : 8400007

Bristol, Connecticut, United States

Novum Research- Site Number : 8400021

Clermont, Florida, United States

Homestead Associates in Research- Site Number : 8400012

Homestead, Florida, United States

Clinical Research of Osceola- Site Number : 8400013

Kissimmee, Florida, United States

Wellness Clinical Research - Miami Lakes - 8181 Northwest 154th Street- Site Number : 8400010

Miami Lakes, Florida, United States

GCP Clinical Research- Site Number : 8400004

Tampa, Florida, United States

GI Alliance - Glenview- Site Number : 8400015

Glenview, Illinois, United States

Illinois Gastroenterology Group- Site Number : 8400011

Gurnee, Illinois, United States

University of Michigan Health System - Ann Arbor- Site Number : 8400017

Ann Arbor, Michigan, United States

GI Alliance - Flowood- Site Number : 8400019

Flowood, Mississippi, United States

Vector Clinical Trials- Site Number : 8400001

Las Vegas, Nevada, United States

Queens Village Primary Medical Center- Site Number : 8400005

Queens Village, New York, United States

Carolina Digestive Diseases and Endoscopy Center- Site Number : 8400014

Greenville, North Carolina, United States

Frontier Clinical Research - Uniontown- Site Number : 8400009

Uniontown, Pennsylvania, United States

Gastro Health & Nutrition- Site Number : 8400003

Katy, Texas, United States

Texas Digestive Disease Consultants - Southlake- Site Number : 8400002

Southlake, Texas, United States

Washington Gastroenterology - Tacoma- Site Number : 8400008

Tacoma, Washington, United States

Investigational Site Number : 0320002

San Miguel de Tucumán, Tucumán Province, Argentina

Investigational Site Number : 0320003

Buenos Aires, Argentina

Investigational Site Number : 0320005

Buenos Aires, Argentina

Investigational Site Number : 0320001

Buenos Aires, Argentina

Investigational Site Number : 0320004

Buenos Aires, Argentina

Investigational Site Number : 0320006

Buenos Aires, Argentina

Investigational Site Number : 0360002

Sydney, New South Wales, Australia

Investigational Site Number : 0360001

South Brisbane, Queensland, Australia

Investigational Site Number : 0360003

Parkville, Victoria, Australia

Centro de Pesquisas da Clínica IBIS- Site Number : 0760001

Salvador, Estado de Bahia, Brazil

Hospital Moinhos de Vento- Site Number : 0760006

Porto Alegre, Rio Grande do Sul, Brazil

Hospital Ernesto Dornelles- Site Number : 0760002

Porto Alegre, Rio Grande do Sul, Brazil

Pesquisare Saude- Site Number : 0760004

Santo André, São Paulo, Brazil

Investigational Site Number : 1000001

Gorna Oryahovitsa, Bulgaria

Investigational Site Number : 1000004

Sofia, Bulgaria

Investigational Site Number : 1000005

Sofia, Bulgaria

Investigational Site Number : 1240001

Calgary, Alberta, Canada

Investigational Site Number : 1240003

Montreal, Quebec, Canada

Investigational Site Number : 1240005

Québec, Quebec, Canada

Investigational Site Number : 1520007

Temuco, La Araucanía, Chile

Investigational Site Number : 1520001

Santiago, Reg Metropolitana de Santiago, Chile

Investigational Site Number : 1520003

Santiago, Reg Metropolitana de Santiago, Chile

Investigational Site Number : 1520002

Viña del Mar, Región de Valparaíso, Chile

Investigational Site Number : 1520006

Concepción, Región del Biobío, Chile

Investigational Site Number : 1520004

Talcahuano, Región del Biobío, Chile

Investigational Site Number : 1560008

Changzhou, China

Investigational Site Number : 1560009

Chongqing, China

Investigational Site Number : 1560012

Fuzhou, China

Investigational Site Number : 1560001

Guangzhou, China

Investigational Site Number : 1560002

Guangzhou, China

Investigational Site Number : 1560004

Hangzhou, China

Investigational Site Number : 1560003

Hangzhou, China

Investigational Site Number : 1560007

Hefei, China

Investigational Site Number : 1560011

Nanchang, China

Investigational Site Number : 1560006

Shanghai, China

Investigational Site Number : 1560005

Shanghai, China

Investigational Site Number : 1560010

Suzhou, China

Investigational Site Number : 1910004

Osijek, Croatia

Investigational Site Number : 1910003

Zagreb, Croatia

Investigational Site Number : 2030003

Brno, Czechia

Investigational Site Number : 2030002

Brno, Czechia

Investigational Site Number : 2030004

Hradec Králové, Czechia

Investigational Site Number : 2500005

Montpellier, France

Investigational Site Number : 2500002

Nice, France

Investigational Site Number : 2500004

Saint-Priest-en-Jarez, France

Investigational Site Number : 2500003

Toulouse, France

Investigational Site Number : 2500001

Vandœuvre-lès-Nancy, France

Investigational Site Number : 2680006

Kutaisi, Georgia

Investigational Site Number : 2680007

Tbilisi, Georgia

Investigational Site Number : 2680001

Tbilisi, Georgia

Investigational Site Number : 2680005

Tbilisi, Georgia

Investigational Site Number : 2680002

Tbilisi, Georgia

Investigational Site Number : 2680003

Tbilisi, Georgia

Investigational Site Number : 2680004

Tbilisi, Georgia

Investigational Site Number : 2760004

Berlin, Germany

Investigational Site Number : 2760002

Berlin, Germany

Investigational Site Number : 2760001

Fulda, Germany

Investigational Site Number : 2760005

Halle, Germany

Investigational Site Number : 2760006

Ludwigshafen, Germany

Investigational Site Number : 3480008

Budapest, Hungary

Investigational Site Number : 3480001

Gyöngyös, Hungary

Investigational Site Number : 3480009

Gyöngyös, Hungary

Investigational Site Number : 3480005

Szeged, Hungary

Investigational Site Number : 3480006

Szekszárd, Hungary

Investigational Site Number : 3480004

Tatabánya, Hungary

Investigational Site Number : 3560007

Hyderabad, India

Investigational Site Number : 3560003

Hyderabad, India

Investigational Site Number : 3560009

Jaipur, India

Investigational Site Number : 3560001

Jaipur, India

Investigational Site Number : 3560005

Kolkata, India

Investigational Site Number : 3560006

Pune, India

Investigational Site Number : 3560002

Secunderabad, India

Investigational Site Number : 3560013

Surat, India

Investigational Site Number : 3560010

Surat, India

Investigational Site Number : 3800009

Milan, Milano, Italy

Investigational Site Number : 3800002

Milan, Milano, Italy

Investigational Site Number : 3800004

Rozzano, Milano, Italy

Investigational Site Number : 3800001

Padua, Padova, Italy

Investigational Site Number : 3800008

Rome, Roma, Italy

Investigational Site Number : 3800006

Rome, Roma, Italy

Investigational Site Number : 3800005

Pisa, Italy

Investigational Site Number : 3920004

Kashiwa, Chiba, Japan

Investigational Site Number : 3920001

Sakura, Chiba, Japan

Investigational Site Number : 3920005

Kitakyushu, Fukuoka, Japan

Investigational Site Number : 3920006

Sapporo, Hokkaido, Japan

Investigational Site Number : 3920010

Sapporo, Hokkaido, Japan

Investigational Site Number : 3920007

Sapporo, Hokkaido, Japan

Investigational Site Number : 3920008

Yahaba, Iwate, Japan

Investigational Site Number : 3920019

Takamatsu, Kagawa-ken, Japan

Investigational Site Number : 3920020

Nagaoka, Niigata, Japan

Investigational Site Number : 3920003

Bunkyo, Tokyo, Japan

Investigational Site Number : 3920013

Hiroshima, Japan

Investigational Site Number : 3920002

Osaka, Japan

Investigational Site Number : 3920018

Ōita, Japan

Investigational Site Number : 3920011

Tokyo, Japan

Investigational Site Number : 3920012

Wakayama, Japan

Investigational Site Number : 4800001

Vacoas, Mauritius

Investigational Site Number : 5280004

Breda, Netherlands

Investigational Site Number : 5280002

Nijmegen, Netherlands

Investigational Site Number : 5280001

Tilburg, Netherlands

Investigational Site Number : 5280003

Utrecht, Netherlands

Investigational Site Number : 6160005

Torun, Kuyavian-Pomeranian Voivodeship, Poland

Investigational Site Number : 6160006

Lublin, Lublin Voivodeship, Poland

Investigational Site Number : 6160004

Warsaw, Masovian Voivodeship, Poland

Investigational Site Number : 6160001

Warsaw, Masovian Voivodeship, Poland

Investigational Site Number : 6160002

Sopot, Pomeranian Voivodeship, Poland

Investigational Site Number : 6420004

Bucharest, Romania

Investigational Site Number : 6420003

Constanța, Romania

Investigational Site Number : 6420001

Timișoara, Romania

Investigational Site Number : 4100002

Haeundae-Gu, Busan, South Korea

Investigational Site Number : 4100001

Daegu, Daegu, South Korea

Investigational Site Number : 4100003

Daejeon, Daejeon, South Korea

Investigational Site Number : 7240002

Seville, Sevilla, Spain

Investigational Site Number : 7240001

Madrid, Spain

Investigational Site Number : 7920003

Istanbul, Turkey (Türkiye)

Investigational Site Number : 7920001

Mersin, Turkey (Türkiye)

Investigational Site Number : 7920002

Zonguldak, Turkey (Türkiye)